Veeva Systems Inc. · NYSE (us_market)
Healthcare · Health Information Services · United States
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2025-12-04$242.28 RISE2026-04-10$151.43 PEAK2026-05-29$174.34 176d | -37.5% 127d | 2026-03-24 $179.11 | Missed | 59Quality on Sale | — | +15.1% 49d | Missed |
DROP2024-12-06$250.45 RISE2025-04-08$209.39 PEAK2025-06-05$289.94 181d | -16.4% 123d | Missed | Missed | — | — | +38.5% 58d | Missed |
DROP2024-12-06$250.45 RISE2024-12-31$210.25 PEAK2025-03-07$246.80 91d | -16.1% 25d | Missed | Missed | — | — | +17.4% 66d | Missed |
DROP2024-03-13$234.79 RISE2024-06-03$171.41 PEAK2024-08-21$201.44 161d | -27.0% 82d | Missed | Missed | — | — | +17.5% 79d | Missed |
DROP2023-09-11$224.90 RISE2023-11-10$165.08 PEAK2024-02-08$215.39 150d | -26.6% 60d | Missed | Missed | — | — | +30.5% 90d | Missed |
DROP2022-11-15$191.66 RISE2023-01-19$158.27 PEAK2023-03-31$183.79 136d | -17.4% 65d | Missed | Missed | — | — | +16.1% 71d | Missed |
DROP2022-08-04$231.91 RISE2022-10-14$151.10 PEAK2022-11-15$191.66 103d | -34.8% 71d | Missed | Missed | — | — | +26.8% 32d | Missed |
DROP2022-01-11$240.04 RISE2022-05-18$153.10 PEAK2022-08-04$231.91 205d | -36.2% 127d | Missed | Missed | — | — | +51.5% 78d | Missed |
DROP2021-11-08$320.45 RISE2022-03-14$170.79 PEAK2022-04-01$216.76 144d | -46.7% 126d | Missed | Missed | — | — | +26.9% 18d | Missed |
DROP2021-08-05$341.00 RISE2021-10-04$279.56 PEAK2021-10-21$325.25 77d | -18.0% 60d | Missed | Missed | — | — | +16.3% 17d | Missed |
DROP2021-02-16$318.09 RISE2021-05-13$245.66 PEAK2021-08-05$341.00 170d | -22.8% 86d | Missed | Missed | — | — | +38.8% 84d | Missed |
DROP2021-02-16$318.09 RISE2021-03-08$241.17 PEAK2021-05-28$291.34 101d | -24.2% 20d | Missed | Missed | — | — | +20.8% 81d | Missed |
DROP2020-10-13$308.55 RISE2020-12-09$258.87 PEAK2021-02-16$318.09 126d | -16.1% 57d | Missed | Missed | — | — | +22.9% 69d | Missed |
DROP2020-02-20$164.97 RISE2020-03-16$120.93 PEAK2020-06-10$226.55 111d | -26.7% 25d | Missed | Missed | — | — | +87.3% 86d | Missed |
VEEV and IQV are benefiting from life sciences digitization trends, but differences in growth, AI adoption and valuation set them apart.
Get a deeper insight into the potential performance of Veeva (VEEV) for the quarter ended April 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Shares of life sciences cloud software provider Veeva Systems (NYSE:VEEV) jumped 3.8% in the afternoon session after the company announced that Kindeva, a global contract development and manufacturing organization (CDMO), would adopt its Veeva Quality Cloud platform to modernize manufacturing operations.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
monday.com delivers cloud-based workflow solutions to a global client base, serving enterprises and institutions across multiple sectors.
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Phreesia (PHR) delivered earnings and revenue surprises of +150.00% and +0.51%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
VEEV's growing Vault CRM adoption and AI momentum, backed by major pharma wins, reinforce confidence in its long-term growth outlook.
VEEV's growing Vault CRM adoption and AI momentum, backed by major pharma wins, reinforce confidence in its long-term growth outlook.
MercadoLibre operates a leading e-commerce and fintech platform serving businesses and consumers across Latin America.
MercadoLibre operates a leading e-commerce and fintech platform serving businesses and consumers across Latin America.
Investors may be wondering whether Veeva Systems, at around US$160 per share, now offers good value or still looks expensive compared to its fundamentals and peers. The stock is up 0.8% over the past week. It is down 2.2% over the past month, 27.0% year to date, 31.3% over the past year, 3.2% over three years and 45.0% over five years, which may influence how you think about risk and potential upside. Recent headlines around healthcare technology and software providers have kept attention on...
Investors may be wondering whether Veeva Systems, at around US$160 per share, now offers good value or still looks expensive compared to its fundamentals and peers. The stock is up 0.8% over the past week. It is down 2.2% over the past month, 27.0% year to date, 31.3% over the past year, 3.2% over three years and 45.0% over five years, which may influence how you think about risk and potential upside. Recent headlines around healthcare technology and software providers have kept attention on...
Strong Growth Stocks screen highlights VEEV (NYSE:VEEV) with solid fundamentals—21.94% EPS growth, zero debt, 9/10 profitability—and a $155.97 support level signaling a potential technical breakout for growth investors.
A number of stocks fell in the afternoon session after Intuit's plunge spread across the sector and reignited the thesis that generative AI is structurally undermining the legacy SaaS business model.
A number of stocks fell in the afternoon session after Intuit's plunge spread across the sector and reignited the thesis that generative AI is structurally undermining the legacy SaaS business model.
Veeva Systems (VEEV) closed the most recent trading day at $158.27, moving 4.06% from the previous trading session.
Veeva Systems (VEEV) closed the most recent trading day at $158.27, moving 4.06% from the previous trading session.
Veeva Systems (VEEV) is rated Buy, trading at multi-year lows despite robust 16% revenue growth, 44% non-GAAP margins, and conservative FY27 guidance.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| VEEV | +1.60% | -3.92% | -21.90% | -37.67% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | -1.37% | +1.80% | -18.46% | -50.36% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 3.61M | $633.90M | 0.02% | Added+0.5% | 2026-03-31 |
| FidelityFMR | fundamental | 2.61M | $459.09M | 0.02% | Trimmed-52.6% | 2026-03-31 |
| TwoSigma | quant | 1.82M | $320.40M | 0.26% | Added+352.1% | 2026-03-31 |
| Wellington | fundamental | 1.54M | $271.26M | 0.05% | Added+16.7% | 2026-03-31 |
| DEShaw | quant | 999.8K | $175.62M | 0.11% | Added+150.3% | 2026-03-31 |
| TRowePrice | fundamental | 2.03M | $357.15K | 0.04% | Added+144.9% | 2026-03-31 |
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-04 | Hung Priscilla | Director | S Open-market sale | 750 | $155.64 | −$116.7K |
| 2026-04-14 | Hung Priscilla | Director | S Open-market sale | 750 | $153.50 | −$115.1K |
| 2026-04-09 | Faddis Jonathan | SVP, Gen. Counsel, Secretary | A Grant / award(deriv) | 0 | — | +$0 |
| 2026-04-03 | Faddis Jonathan | SVP, Gen. Counsel, Secretary | M Option exercise(deriv) | 1,226 | — | +$0 |
| 2026-04-03 | Faddis Jonathan | SVP, Gen. Counsel, Secretary | M Option exercise(deriv) | 7,500 | — | +$0 |
| 2026-04-03 | Faddis Jonathan | SVP, Gen. Counsel, Secretary | F Tax withholding | 440 | $172.74 | −$76.0K |
| 2026-04-03 | Faddis Jonathan | SVP, Gen. Counsel, Secretary | M Option exercise | 1,226 | — | +$0 |
| 2026-04-03 | Faddis Jonathan | SVP, Gen. Counsel, Secretary | F Tax withholding | 3,370 | $172.74 | −$582.1K |
| 2026-04-03 | Faddis Jonathan | SVP, Gen. Counsel, Secretary | M Option exercise | 7,500 | — | +$0 |
| 2026-04-03 | Zuppas Eleni Nitsa | President & Chief of Staff | M Option exercise(deriv) | 1,498 | — | +$0 |
| 2026-04-03 | Zuppas Eleni Nitsa | President & Chief of Staff | M Option exercise(deriv) | 7,500 | — | +$0 |
| 2026-04-03 | Zuppas Eleni Nitsa | President & Chief of Staff | F Tax withholding | 538 | $172.74 | −$92.9K |
| 2026-04-03 | Zuppas Eleni Nitsa | President & Chief of Staff | M Option exercise | 1,498 | — | +$0 |
| 2026-04-03 | Zuppas Eleni Nitsa | President & Chief of Staff | F Tax withholding | 3,464 | $172.74 | −$598.4K |
| 2026-04-03 | Zuppas Eleni Nitsa | President & Chief of Staff | M Option exercise | 7,500 | — | +$0 |
| 2026-04-03 | Kondath Vipin | Chief Accounting Officer | M Option exercise(deriv) | 103 | — | +$0 |
| 2026-04-03 | Kondath Vipin | Chief Accounting Officer | M Option exercise(deriv) | 2,500 | — | +$0 |
| 2026-04-03 | Kondath Vipin | Chief Accounting Officer | F Tax withholding | 43 | $172.74 | −$7.4K |
| 2026-04-03 | Kondath Vipin | Chief Accounting Officer | M Option exercise | 103 | — | +$0 |
| 2026-04-03 | Kondath Vipin | Chief Accounting Officer | F Tax withholding | 914 | $172.74 | −$157.9K |
| 2026-04-03 | Kondath Vipin | Chief Accounting Officer | M Option exercise | 2,500 | — | +$0 |
| 2026-04-03 | Schwenger Thomas D. | Pres. & Chief Customer Officer | M Option exercise(deriv) | 2,043 | — | +$0 |
| 2026-04-03 | Schwenger Thomas D. | Pres. & Chief Customer Officer | F Tax withholding | 588 | $172.74 | −$101.6K |
| 2026-04-03 | Schwenger Thomas D. | Pres. & Chief Customer Officer | M Option exercise | 2,043 | — | +$0 |
| 2026-04-03 | Van Wagener Brian | Chief Financial Officer | M Option exercise(deriv) | 872 | — | +$0 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-06-03upcoming | 2.14 | — | — |
| 2026-03-04 | 1.94 | 2.06 | +6.45% |
| 2025-11-20 | 1.95 | 2.04 | +4.55% |
| 2025-08-27 | 1.90 | 1.99 | +4.75% |
| 2025-05-28 | 1.74 | 1.97 | +12.98% |
| 2025-03-05 | 1.58 | 1.74 | +10.05% |
| 2024-12-05 | 1.58 | 1.75 | +10.70% |
| 2024-08-28 | 1.53 | 1.62 | +5.61% |
| 2024-05-30 | 1.42 | 1.50 | +5.27% |
| 2024-02-29 | 1.30 | 1.38 | +6.22% |
| 2023-12-06 | 1.29 | 1.34 | +3.69% |
| 2023-08-30 | 1.13 | 1.21 | +7.30% |
| 2023-05-31 | 0.80 | 0.91 | +13.55% |
| 2023-03-01 | 1.04 | 1.15 | +10.62% |
| 2022-12-01 | 1.07 | 1.13 | +5.31% |
| 2022-08-31 | 1.01 | 1.03 | +1.95% |